Solid Biosciences Inc. SLDB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$56.74M-14.0% | -$49.79M-8.8% | -$45.78M-15.9% | -$39.48M-0.5% | -$39.28M+7.8% | ||
| $395K-15.4% | $467K+24.2% | $376K-2.6% | $386K-5.2% | $407K-16.6% | ||
| $5.15M-20.7% | $6.5M+65.5% | $3.93M+24.9% | $3.15M-5.9% | $3.34M-12.6% | ||
| $2.32M+144% | -$5.26M-242% | $3.7M+61,517% | $6K-98.7% | $461K-43.4% | ||
| -$473K-411% | $152K-93.1% | $2.2M+11.8% | $1.97M+816% | -$275K-117% | ||
| -$954K-112% | $7.65M— | —— | $4.08M+302% | -$2.02M— | ||
| $0— | $0-100% | $294K+482% | -$77K-450% | $22K0.0% | ||
| -$496K-0.2% | -$495K-11.7% | -$443K-2.5% | -$432K-3.8% | -$416K-0.5% | ||
| -$47.23M+11.8% | -$53.56M-60.0% | -$33.47M+10.5% | -$37.41M-17.5% | -$31.85M-7.4% | ||
| $165K-70.8% | $565K+565% | $85K-77.5% | $377K+199% | $126K-38.2% | ||
| $83.46M+249% | $23.92M-71.2% | $83.19M+31.1% | $63.44M-2.9% | $65.34M+326% | ||
| $44.76M— | —— | -$45.27M-38.3% | -$32.73M-19.2% | -$27.46M— | ||
| $0-100% | $203K-16.5% | $243K+71.1% | $142K+5.2% | $135K+5.5% | ||
| $18K— | —— | —— | $6K— | $0-100% | ||
| $239.03M+4,548% | $5.14M+337% | $1.18M— | $0-100% | $189.73M+2,634% | ||
| $236.56M+17,021% | -$1.4M+98.2% | -$77.57M-8.1% | -$71.75M-155% | $130.42M+722% | ||
| $0— | —— | —— | $60K-11.8% | $68K— | ||
| $619K-17.1% | $747K+128% | $327K-33.0% | $488K+56.4% | $312K-61.1% | ||
| -$1.65M+37.7% | -$2.65M-212% | -$850K+5.6% | -$900K+45.5% | -$1.65M-135% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| -$473K-411% | $152K-93.1% | $2.2M+11.8% | $1.97M+816% | -$275K-117% | ||
| -$496K-0.2% | -$495K-11.7% | -$443K-2.5% | -$432K-3.8% | -$416K-0.5% | ||
| -$954K-112% | $7.65M— | —— | $4.08M+302% | -$2.02M— | ||
| $623K+2.0% | $611K+2.2% | $598K+1.9% | $587K+2.1% | $575K+1.8% | ||
| $0— | $0-100% | $294K+482% | -$77K-450% | $22K0.0% | ||
| -$128.38M-79.6% | -$71.5M-88.2% | -$38M-22.6% | -$31M+18.4% | -$38M+29.8% | ||
| $0— | —— | —— | $1.66M+8,205% | $20K— | ||
| $12.89M— | $0— | $0— | $0— | $0— | ||
| $0— | —— | —— | —— | $189.64M— | ||
| $239.97M— | —— | —— | $0— | $0— | ||
| $11.93M— | —— | $1.42M— | —— | $246K— | ||
| $0-100% | $203K-16.5% | $243K+71.1% | $142K+5.2% | $135K+5.5% | ||
| $25K— | —— | $329K+511% | -$80K-200% | $80K+322% | ||
| $7.5M— | —— | —— | —— | $5M— | ||
| -$496K-0.2% | -$495K-11.7% | -$443K-2.5% | -$432K-3.8% | -$416K-0.5% | ||
| —— | $0— | $0— | $0— | $0+100% | ||
| —— | $1.04M0.0% | $1.04M0.0% | $1.04M0.0% | $1.04M-2.1% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | $22.75K0.0% | $22.75K0.0% | $22.75K0.0% | $22.75K-80.6% | ||
| —— | $180.75K0.0% | $180.75K0.0% | $180.75K0.0% | $180.75K+113% | ||
| -$47.4M+12.4% | -$54.12M-61.3% | -$33.56M+11.2% | -$37.79M-18.2% | -$31.98M-7.1% | ||
| -$47.4M+12.4% | -$54.12M-61.3% | -$33.56M+11.2% | -$37.79M-18.2% | -$31.98M-7.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Solid Biosciences Inc. generate?
- Solid Biosciences Inc. (SLDB) generated -$171.7M in operating cash flow over the trailing twelve months.
- What is Solid Biosciences Inc.'s free cash flow?
- After $1.2M of capital expenditures, Solid Biosciences Inc.'s free cash flow was -$172.9M over the trailing twelve months, down 61.1% year over year.
- Where does Solid Biosciences Inc.'s cash flow data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
